Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 2.48% · OPTIONAL
· Services-Business Services, NEC
RESEARCH SNAPSHOTCALLAN JMB INC.'s latest supported as-filed period reports revenue of $1.4M, 17.4% below the comparable as-filed period; gross margin moved 1643 basis points higher on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 2.48% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -28.78% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -17.40% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 14.43% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 55.07% · CORE
Level · gp.fundamentals.operating_margin
Raw value -97.84% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Inventory increased 0.5%; Inventory / revenue moved 258 bp higher.
2 evidence-backed componentsGross margin changed +1643 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Each point keeps the date investors could first observe it and its accession.
CJMB · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001493152-26-041017SEC ↗8-KAug 31, 2026Period Aug 26, 20260001493152-26-040838SEC ↗8-KAug 24, 2026Period Aug 19, 20260001493152-26-039761SEC ↗8-KAug 20, 2026Period Aug 18, 20260001493152-26-039329SEC ↗10-QAug 14, 2026Period Jun 30, 20260001493152-26-038329SEC ↗8-KJul 2, 2026Period Jun 29, 20260001493152-26-031963SEC ↗8-KJun 11, 2026Period Jun 5, 20260001493152-26-028275SEC ↗4Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Mar 20, 2026Filed Mar 26, 2026 | Croyle David JChief Medical Officer | Open Market PurchaseIndirect | 10,195 | $2 | $17,841 | Form 4 ↗ |
| Mar 6, 2026Filed Mar 10, 2026 | Croyle David JChief Medical Officer | Open Market PurchaseIndirect | 14,805 | $2 | $26,086 | Form 4 ↗ |
| Dec 30, 2025Filed Jun 1, 2026 | Dial GeraldDirector | Open Market PurchaseDirect | 10,000 | $1 | $7,620 | Form 4 ↗ |
| Dec 30, 2025Filed Jan 6, 2026 | Dial GeraldDirector | Open Market PurchaseDirect | 461 | $1 | $562 | Form 4 ↗ |
| Dec 30, 2025 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Level · gp.fundamentals.sbc_revenue_ratio
Raw value 22.83% · OPTIONAL
Operating margin changed -1367 basis points from the comparable as-filed period.
Cash & equivalents changed -79.6% from the comparable as-filed period.
Revenue changed -17.4% from the comparable as-filed period.
Net income changed +11.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory / revenue changed +258 basis points from the comparable as-filed period.
Operating income changed +4.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001493152-26-026557| Dial GeraldDirector |
| Open Market PurchaseDirect |
| 1,539 |
| $1 |
| $1,847 |
| Form 4 ↗ |
| Dec 16, 2025Filed Dec 18, 2025 | Williams Wayne DCEO, Chairman and President | Open Market PurchaseIndirect | 5,000 | $2 | $8,650 | Form 4 ↗ |
| Dec 15, 2025Filed Dec 15, 2025 | Williams Wayne DCEO, Chairman and President | Open Market PurchaseIndirect | 10,810 | $2 | $18,377 | Form 4 ↗ |
| Dec 12, 2025Filed Dec 15, 2025 | Williams Wayne DCEO, Chairman and President | Open Market PurchaseDirect | 4,926 | $2 | $8,621 | Form 4 ↗ |
| Dec 11, 2025Filed Dec 15, 2025 | Williams Wayne DCEO, Chairman and President | Open Market PurchaseDirect | 62 | $2 | $111 | Form 4 ↗ |
| Dec 11, 2025Filed Dec 12, 2025 | Williams Wayne DCEO, Chairman and President | Open Market PurchaseIndirect | 30,856 | $2 | $50,912 | Form 4 ↗ |
| Dec 10, 2025Filed Dec 12, 2025 | Williams Wayne DCEO, Chairman and President | Open Market PurchaseIndirect | 13,689 | $2 | $22,587 | Form 4 ↗ |
| Dec 9, 2025Filed Dec 10, 2025 | Duke Liberty SmithDirector | Open Market PurchaseDirect | 612 | $2 | $930 | Form 4 ↗ |
| Dec 8, 2025Filed Dec 10, 2025 | Duke Liberty SmithDirector | Open Market PurchaseDirect | 900 | $2 | $1,404 | Form 4 ↗ |
| Mar 27, 2025Filed Apr 3, 2025 | Croyle David JChief Medical Officer | Open Market PurchaseIndirect | 25,000 | $5 | $112,500 | Form 4 ↗ |
| Feb 5, 2025Filed Mar 14, 2025 | Williams Wayne DCEO and President | Open Market PurchaseDirect | 12,500 | $4 | $50,000 | Form 4 ↗ |
| Feb 5, 2025Filed Mar 14, 2025 | Williams Wayne DCEO and President | Open Market PurchaseIndirect | 25,625 | $4 | $102,500 | Form 4 ↗ |
| Feb 5, 2025Filed Mar 14, 2025 | Williams Wayne DCEO and President | Open Market PurchaseIndirect | 25,000 | $4 | $100,000 | Form 4 ↗ |
| Feb 5, 2025Filed Mar 14, 2025 | Croyle David JChief Medical Officer | Open Market PurchaseIndirect | 24,375 | $4 | $97,500 | Form 4 ↗ |
| Feb 4, 2025Filed Jun 1, 2026 | Dial GeraldDirector | Grant Or AwardDirect | 25,000 | $4 | $100,000 | Form 4 ↗ |
| Feb 4, 2025Filed Jan 6, 2026 | Dial GeraldDirector | Grant Or AwardDirect | 25,000 | $4 | $100,000 | Form 4 ↗ |